← Leaderboards
Thomas Martin Vondriska
University Of California Los Angeles
$19,397,244
Attributed
$23,246,048
Total exposure
13
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$23,744,371 · 14
By mechanism
R01$19,661,026 · 8
P01$2,234,199 · 1
S10$996,646 · 3
R21$852,500 · 2
Top collaborators
- Timothy Mckinsey4 shared
- Kunhua Song4 shared
- Yibin Wang3 shared
- David Joseph Lefer1 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Ronald T Mitsuyasu$121,811,876
- Ira Kurtz$12,453,596
Others in their field
Top investigators on “Cardiac”
- Judith S Hochman · New York University School Of Medicine$110,228,771
- Anne Christine Gelijns · Icahn School Of Medicine At Mount Sinai$69,868,084
- Rose A Gubitosi-Klug · Case Western Reserve University$61,225,818
- Alfred G Gilman · University Of Texas Sw Med Ctr/Dallas$53,141,827
- Joseph C Wu · Stanford University$53,027,789
- Pamela Susan Douglas · Duke University$51,506,531
Research focus
CardiacHeartResponseCellsProteinsPhenotypeHeart FailureGenesRegulationGene ExpressionAdultChromatinMuscle CellsInvestigationPathologicStressPressureMolecularHeart DiseasesGenomeProteomicsGenomicsCell TypeComplex
Grant awards (54)
Epigenetic Regulation of Heart Failure with Preserved Ejection Fraction$699,133
R01 · FY2025 · HL · contact PI
Regulation of gene transcription and alternative splicing by a long non-coding RNA$505,728
R01 · FY2025 · HL
Dynamics of cardiac nuclei in heart disease$390,000
R01 · FY2025 · HL · contact PI
Regulation of gene transcription and alternative splicing by a long non-coding RNA$506,434
R01 · FY2024 · HL
Dynamics of cardiac nuclei in heart disease$390,000
R01 · FY2024 · HL · contact PI
Small molecule therapies targeting chromatin architecture in heart failure$720,487
R01 · FY2023 · HL · contact PI
Regulation of gene transcription and alternative splicing by a long non-coding RNA$546,379
R01 · FY2023 · HL
Dynamics of cardiac nuclei in heart disease$390,000
R01 · FY2023 · HL · contact PI
Small molecule therapies targeting chromatin architecture in heart failure$720,487
R01 · FY2022 · HL · contact PI
Regulation of gene transcription and alternative splicing by a long non-coding RNA$574,874
R01 · FY2022 · HL
Dynamics of cardiac nuclei in heart disease$390,000
R01 · FY2022 · HL · contact PI
Small molecule therapies targeting chromatin architecture in heart failure$720,487
R01 · FY2021 · HL · contact PI
Novel Mechanisms of LncRNA Mediated Epigenetic Regulation in Cardiac Hypertrophy$537,696
R01 · FY2021 · HL · contact PI
Epigenomic basis of resilience to heart failure$195,000
R21 · FY2021 · HL · contact PI
Small molecule therapies targeting chromatin architecture in heart failure$734,487
R01 · FY2020 · HL · contact PI
Novel Mechanisms of LncRNA Mediated Epigenetic Regulation in Cardiac Hypertrophy$537,696
R01 · FY2020 · HL · contact PI
Dynamics of Cardiac Nuclei in Heart Disease$390,000
R01 · FY2020 · HL · contact PI
Epigenomic basis of resilience to heart failure$234,000
R21 · FY2020 · HL · contact PI
Novel Mechanisms of LncRNA Mediated Epigenetic Regulation in Cardiac Hypertrophy$537,696
R01 · FY2019 · HL · contact PI
Dynamics of Cardiac Nuclei in Heart Disease$390,000
R01 · FY2019 · HL · contact PI
Epigenomic Mechanisms of Heart Failure$656,371
R01 · FY2018 · HL · contact PI
Novel Mechanisms of LncRNA Mediated Epigenetic Regulation in Cardiac Hypertrophy$537,696
R01 · FY2018 · HL · contact PI
Dynamics of Cardiac Nuclei in Heart Disease$389,792
R01 · FY2018 · HL · contact PI
Epigenomic Mechanisms of Heart Failure$656,371
R01 · FY2017 · HL · contact PI
Dynamics of Cardiac Nuclei in Heart Disease$387,292
R01 · FY2017 · HL · contact PI
Epigenomic Mechanisms of Heart Failure$656,371
R01 · FY2016 · HL · contact PI
Systems Analysis of Cardiac Chromatin Structure$385,000
R01 · FY2016 · HL · contact PI
Epigenomic Mechanisms of Heart Failure$656,371
R01 · FY2015 · HL · contact PI
Systems Analysis of Cardiac Chromatin Structure$379,225
R01 · FY2015 · HL · contact PI
Dynamics of Cardiac Nuclei in Heart Disease$379,225
R01 · FY2015 · HL · contact PI
Systems Analysis of Cardiac Chromatin Structure$377,300
R01 · FY2014 · HL · contact PI
Dynamics of Cardiac Nuclei in Heart Disease$377,300
R01 · FY2014 · HL · contact PI
Dynamics of Cardiac Nuclei in Heart Disease$366,520
R01 · FY2013 · HL · contact PI
Systems Analysis of Cardiac Chromatin Structure$366,520
R01 · FY2013 · HL · contact PI
Systems Analysis of Cardiac Chromatin Structure$385,000
R01 · FY2012 · HL · contact PI
Dynamics of Cardiac Nuclei in Heart Disease$385,000
R01 · FY2012 · HL · contact PI
Novel mechanisms of tyrosine kinase signaling in heart$386,250
R01 · FY2011 · HL · contact PI
Dynamics of Cardiac Nuclei in Heart Disease$385,000
R01 · FY2011 · HL · contact PI
Novel mechanisms of tyrosine kinase signaling in heart$424,750
R01 · FY2010 · HL · contact PI
Phenotypic Continuum Between Cardiac Growth and Protection$192,500
R21 · FY2010 · HL · contact PI
Core A-PROTEOMIC CORE$477,204
P01 · FY2009 · HL · contact PI
Novel mechanisms of tyrosine kinase signaling in heart$472,490
R01 · FY2009 · HL · contact PI
Phenotypic Continuum Between Cardiac Growth and Protection$231,000
R21 · FY2009 · HL · contact PI
Novel mechanisms of tyrosine kinase signaling in heart$226,608
R01 · FY2009 · HL · contact PI
Core A-PROTEOMIC CORE$454,087
P01 · FY2008 · HL · contact PI
Novel mechanisms of tyrosine kinase signaling in heart$347,625
R01 · FY2008 · HL · contact PI
Novel mechanisms of tyrosine kinase signaling in heart$47,740
R01 · FY2008 · HL · contact PI
Core A-PROTEOMIC CORE$449,947
P01 · FY2007 · HL · contact PI
Novel mechanisms of tyrosine kinase signaling in heart$347,625
R01 · FY2007 · HL · contact PI
Purchase of Proteomic Mass Spectrometry Instrumentation$498,323
S10 · FY2006 · RR · contact PI
Core A-PROTEOMIC CORE$428,058
P01 · FY2006 · HL · contact PI
PURCHASE OF PROTEOMIC MASS SPECTROMETRY INSTRUMENTATION: CARDIOLOGY$274,078
S10 · FY2006 · RR · contact PI
PURCHASE OF PROTEOMIC MASS SPECTROMETRY INSTRUMENTATION: ATHEROSCLEROSIS$224,245
S10 · FY2006 · RR · contact PI
Core A-PROTEOMIC CORE$424,903
P01 · FY2005 · HL